FDA DEVICE FACTS
Powder-Free Blue Nitrile Examination Gloves (Tested for use with Chemotherapy and Fentanyl) – Regular Cuff; Powder-Free Blue Nitrile Examination Gloves (Tested for use with Chemotherapy Drugs and Fentanyl) - Extended Cuff
Medline Industries, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
A patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. Chemo Drugs Tested: Aresenic Trioxide 1 mg/ml (1,000 ppm) Azacitidine 25 mg/ml (25,000 ppm) Bendamustine 5 mg/ml (5,000 ppm) Bleomycin 15 mg/ml (15,000 ppm) Bortezomib 1 mg/ml (1,000 ppm) Busulfan 6 mg/ml (6,000 ppm) Carboplatin 10.0 mg/ml (10,000 ppm) Carfilzomib 2.0 mg/ml (2,000) Carmustine (BCNU) 3.3 mg/ml (3,300 ppm) Cetuximab 2.0 mg/ml (2,000) Cisplatin 1.0 mg/ml (1,000 ppm) Cyclophosphamide (Cytoxan) 20.0 mg/ml (20,000 ppm) Cytarabine 100 mg/ml (100,000 ppm) Cytovene 10 mg/ml (10,000 ppm) Dacarbazine (DTIC) 10.0 mg/ml (10,000 ppm) Daunorubicin 5 mg/ml (5,000 ppm) Decitabine 5 mg/ml (5,000 ppm) Docetaxel 10.0 mg/ml (10,000 ppm) Doxorubicin Hydrochloride 2.0 mg/ml (2,000 ppm) Epirubicin (Ellence) 2.0 mg/ml (2,000 ppm) Etoposide (Toposar) 20.0 mg/ml (20,000 ppm) Fludarabine 25 mg/ml (25,000 ppm) Fluorouracil 50.0 mg/ml (50,000 ppm) Fulvestrant 50.0 mg/ml (50,000 ppm) Gemcitabine (Gemzar) 38 mg/ml (38,000 ppm) Idarubicin 1 mg/ml (1,000 ppm) lfosfamide 50.0 mg/ml (50,000 ppm) Irinotecan 20.0 mg/ml (20,000 ppm) Mechlorethamine HCI 1.0 mg/ml (1,000 ppm) Melphalan 5 mg/ml (5,000 ppm) Methotrexate 25 mg/ml (25,000 ppm) Mitomycin C 0.5 mg/ml (500 ppm) Mitoxantrone 2.0 mg/ml (2,000 ppm) Oxaliplatin 2.0 mg/ml (2,000 ppm) Paclitaxel (Taxol) 6.0 mg/ml (6,000 ppm) Paraplatin 10 mg/ml (10,000 ppm) Pemetrexed Disodium 25.0 mg/ml (25,000 ppm) Pertuzumab 30 mg/ml (30,000 ppm) Raltitrexed 0.5 mg/ml (500 ppm) Breakthrough Time (Minutes) >240 >240 >240 >240 >240 >240 >240 >240 33.1 min >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 Retrovir 10.0 mg/ml (10,000 ppm) Rituximab 10 mg/ml (10,000 ppm) Temsirolimus 25.0 mg/ml (25,000 ppm) Thiotepa 10.0 mg/ml (10,000 ppm) Topotecan HCI 1.0 mg/ml (1,000 ppm) Trastuzumab 21.0 mg/ml (21,000 ppm) Trisonex 1 mg/ml (1,000 ppm) Vinblastine 1 mg/ml (1,000 ppm) Vincristine Sulfate 1.0 mg/ml (1,000 ppm) Vinorelbine 10 mg/ml (10,000 ppm) Zoledronic Acid 0.8 mg/ml (800 ppm) Fentanyl Citrate, 100mcg/2mL >240 >240 >240 69.2 min >240 >240 >240 >240 >240 >240 >240 62.0 min Please note that the following drug has low permeation time: Carmustine (BCNU) (3.3 mg/ml) 33.1 minutes CAUTION: Testing showed an average breakthrough time of33.l minutes with Carmustine >240 and 69.2 minutes with Thiotepa Thiotepa (THT) (10.0mg/ml) 69.2 minutes A patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. Chemotherapy Drug Tested Aresenic Trioxide 1 mg/ml Azacitidine 25 mg/ml Bendamustine 5 mg/ml Bleomycin 15 mg/m Bortezomib 1 mg/ml Busulfan 6 mg/ml Carfilzomib 2 mg/ml Carmustine (BCNU) 3 .3 mg/ml Cetuximab Cisplatin 1.0 mg/ml Cyclophosphamide (Cytoxan) 20.0 mg/ml Cytarabine Hydrochloride 100 mg/ml Cytovene 10 mg/ml Dacarbazine (DTIC) 10.0 mg/ml Daunorubicin 5 mg/ml Decitabine 5 mg/ml Docetaxel 10.0 mg/ml Doxorubicin Hydrochloride 2.0 mg/ml Epirubicin (Ellence) 2.0 mg/ml Etoposide (Toposar) 20.0 mg/ml Fludarabine 25 mg/ml Fluorouracil 50.0 mg/ml Fulvestrant 50.0 mg/ml Gemcitabine (Gemzar) 38 mg/ml Idarubicin 1 mg/ml lfosfamide 50.0 mg/ml Irinotecan 20.0 mg/ml Mechlorethamine HCI 1.0 mg/ml Melphalan 5 mg/ml Methotrexate 25.0 mg/ml Mitomycin C 0.5 mg/ml Mitoxantrone 2mg/ml Oxaliplatin 5.0 mg/ml Paclitaxel (Taxol) 6.0 mg/ml Paraplatin (Carboplatin) 10 mg/ml Pemetrexed Disodium 25.0 mg/ml Pertuzumab 3 0 mg/ml Raltitrexed 0.5 mg/ml Retrovir 10.0 mg/ml Breakthrough Time (in minutes) >240 >240 >240 >240 >240 >240 >240 59.4 min >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 Rituximab 10 mg/ml Temsirolimus 25.0 mg/ml Thiotepa 10.0 mg/ml Topotecan HCI 1.0 mg/ml Trastuzumab 21.0 mg/ml Trisonex 1 mg/ml Vinblastine 1 mg/ml Vincristine Sulfate 1.0 mg/ml Vinorelbine 10 mg/ml Zoledronic Acid 0.8 mg/ml Fentanyl Citrate, 100mcg/2mL >240 >240 68.2 min >240 >240 >240 >240 >240 >240 >240 167.8 min Please note that the following drug has low permeation time: Carmustine (BCNU) (3 .3 mg/ml) 59 .4 minutes CAUTION: Testing showed an average breakthrough time of 59.4 minutes with Carmustine >240 Thiotepa (THT) (10.0 mg/ml) 68.2 minutes and 68.2 minutes with Thiotepa
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。